Millions of Americans got COVID-19 booster shots at a near record pace after the Biden administration expanded eligibility last week, but health officials concerned about climbing infections ahead of the winter holiday season urged more to get the additional protection.

The U.S. Food and Drug Administration approved Covid-19 vaccine booster shots for all Americans ages 18 and over Friday morning.  

Moderna Inc. said on November 17 the company had applied with the U.S. Food and Drug Administration for authorization of the Covid-19 booster vaccine for all adults aged 18 and older.

The U.S. Food and Drug Administration said on November 16 it would review Pfizer Inc.’s request to authorize booster doses of the company’s Covid-19 vaccine in all adults “as expeditiously as possible,” with the New York Times reporting that the regulatory nod could come as soon as November 18.

The United States administered over 9.5 million doses of Covid-19 vaccines in the past seven days, the highest weekly total since late May, a White House official said on November 13.

In a rebuttal to the National Institutes of Health’s claims on its COVID-19 patents, Moderna said company scientists exclusively selected its RNA sequence. Also, the company said the sequence was selected with Moderna technology and without the input of NIH scientists.

Alien babies? Scary ingredients? Gen Z and Millennials are being inundated with misinformation around COVID vaccination. Klick Health and The Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine (VCP) are trying to change that by reaching 18-30 year olds on a platform they use regularly: YouTube.

Europe’s drug regulator on November 11 recommended adding a rare type of spinal inflammation called transverse myelitis as a side effect of Johnson & Johnson’s single-dose Covid-19 vaccine.

U.S. National Institutes of Health scientists played “a major role” in developing Moderna Inc.’s Covid-19 vaccine and the agency intends to defend its claim as co-owner of patents on the shot, NIH Director Dr. Francis Collins told Reuters on November 10.

A consumer rights advocacy group is crying foul over Moderna’s omission of government scientists in some credits for the company’s Covid-19 vaccine patent application. Moderna and scientists from the National Institutes of Health (NIH) worked together to develop the company’s mRNA vaccine against SARS-CoV-2.